{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:54:54Z","timestamp":1792007694695,"version":"4.4.0"},"reference-count":111,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.3892\/ijo.2014.2552","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T08:17:22Z","timestamp":1406017042000},"page":"1363-1371","source":"Crossref","is-referenced-by-count":118,"title":["TGF-\u03b2\/Smad signaling during hepatic fibro-carcinogenesis (Review)"],"prefix":"10.3892","volume":"45","author":[{"given":"KATSUNORI","family":"YOSHIDA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIKI","family":"MURATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKASHI","family":"YAMAGUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOICHI MATSU","family":"ZAKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"key20180107181600_b1-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-beta in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res"},{"key":"key20180107181600_b2-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/egh.10.47","article-title":"Update on the pathophysiology of liver fibrosis","volume":"4","author":"Pinzani","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key20180107181600_b3-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0168-8278(98)80280-8","article-title":"Differential expression of transforming growth factor-beta and its receptors in hepatocytes and nonparenchymal cells of rat liver after CCl4 administration","volume":"28","author":"Date","year":"1998","journal-title":"J Hepatol"},{"key":"key20180107181600_b4-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/gut.46.5.719","article-title":"Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury","volume":"46","author":"Date","year":"2000","journal-title":"Gut"},{"key":"key20180107181600_b5-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3181\/0707-MR-190","article-title":"Mechanisms of fibrogenesis","volume":"233","author":"Kisseleva","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"key":"key20180107181600_b6-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0959-437X(96)80087-6","article-title":"Regulation of differentiation by TGF-beta","volume":"6","author":"Moses","year":"1996","journal-title":"Curr Opin Genet Dev"},{"key":"key20180107181600_b7-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-3-642-49295-2_8","article-title":"The transforming growth factor-\u03b2s","volume-title":"Peptide Growth Factors and Their Receptors I","author":"Roberts","year":"1990"},{"key":"key20180107181600_b8-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4419-6033-7_5","article-title":"Tgf-beta signaling alterations and colon cancer","volume":"155","author":"Bellam","year":"2010","journal-title":"Cancer Treat Res"},{"key":"key20180107181600_b9-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/carcin\/bgr172","article-title":"Smad phosphoisoform signaling specificity: the right place at the right time","volume":"32","author":"Matsuzaki","year":"2011","journal-title":"Carcinogenesis"},{"key":"key20180107181600_b10-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00441-011-1178-6","article-title":"Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells","volume":"347","author":"Matsuzaki","year":"2012","journal-title":"Cell Tissue Res"},{"key":"key20180107181600_b11-ijo-45-04-1363","volume-title":"The TGF-\u03b2 Signaling","author":"Derynck","year":"2008"},{"key":"key20180107181600_b12-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"key20180107181600_b13-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1101\/gad.13.7.804","article-title":"A mechanism of repression of TGFbeta\/Smad signaling by oncogenic Ras","volume":"13","author":"Kretzschmar","year":"1999","journal-title":"Genes Dev"},{"key":"key20180107181600_b14-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature02650","article-title":"Cyclin-dependent kinases regulate the antiproliferative function of Smads","volume":"430","author":"Matsuura","year":"2004","journal-title":"Nature"},{"key":"key20180107181600_b15-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1158\/0008-5472.CAN-08-4203","article-title":"Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer","volume":"69","author":"Matsuzaki","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107181600_b16-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1074\/jbc.M403960200","article-title":"Role of Rho\/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo","volume":"280","author":"Kamaraju","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107181600_b17-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1128\/MCB.20.21.8103-8111.2000","article-title":"Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II","volume":"20","author":"Wicks","year":"2000","journal-title":"Mol Cell Biol"},{"key":"key20180107181600_b18-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.1840380414","article-title":"p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts","volume":"38","author":"Furukawa","year":"2003","journal-title":"Hepatology"},{"key":"key20180107181600_b19-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1038\/sj.onc.1207981","article-title":"TGF-beta and HGF transmit the signals through JNK-dependent Smad2\/3 phosphorylation at the linker regions","volume":"23","author":"Mori","year":"2004","journal-title":"Oncogene"},{"key":"key20180107181600_b20-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1038\/sj.emboj.7600794","article-title":"The G protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal transduction","volume":"24","author":"Ho","year":"2005","journal-title":"EMBO J"},{"key":"key20180107181600_b21-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"19808","DOI":"10.1074\/jbc.M109.016667","article-title":"A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204","volume":"284","author":"Millet","year":"2009","journal-title":"J Biol Chem"},{"key":"key20180107181600_b22-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","article-title":"Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways","volume":"139","author":"Alarcon","year":"2009","journal-title":"Cell"},{"key":"key20180107181600_b23-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cytogfr.2013.06.002","article-title":"Smad phospho-isoforms direct context-dependent TGF-beta signaling","volume":"24","author":"Matsuzaki","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20180107181600_b24-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/0008-5472.157.65.1","article-title":"Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis","volume":"65","author":"Yamagata","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107181600_b25-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1158\/0008-5472.CAN-06-4629","article-title":"Reversible Smad-dependent signaling between tumor suppression and oncogenesis","volume":"67","author":"Sekimoto","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107181600_b26-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0002-9440(10)62324-3","article-title":"Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2\/3 phosphorylation in rat hepatic stellate cells after acute liver injury","volume":"166","author":"Yoshida","year":"2005","journal-title":"Am J Pathol"},{"key":"key20180107181600_b27-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.21672","article-title":"Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma","volume":"46","author":"Matsuzaki","year":"2007","journal-title":"Hepatology"},{"key":"key20180107181600_b28-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.22765","article-title":"Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B","volume":"49","author":"Murata","year":"2009","journal-title":"Hepatology"},{"key":"key20180107181600_b29-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.22860","article-title":"Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor-suppression in rat hepatocellular carcinoma","volume":"49","author":"Nagata","year":"2009","journal-title":"Hepatology"},{"key":"key20180107181600_b30-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ibd.21395","article-title":"Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis","volume":"17","author":"Kawamata","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key20180107181600_b31-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/hepr.12082","article-title":"Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C","volume":"43","author":"Yamaguchi","year":"2013","journal-title":"Hepatol Res"},{"key":"key20180107181600_b32-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cei.12259","article-title":"Reversible phospho-Smad3 signaling between tumor-suppression and fibro-carcinogenesis in chronic hepatitis B infection","volume":"176","author":"Deng","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"key20180107181600_b33-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-beta signaling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"Heldin","year":"1997","journal-title":"Nature"},{"key":"key20180107181600_b34-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","article-title":"Specificity and versatility in tgf-beta signaling through Smads","volume":"21","author":"Feng","year":"2005","journal-title":"Annu Rev Cell Dev Biol"},{"key":"key20180107181600_b35-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1242\/jcs.113.7.1101","article-title":"Positive and negative regulation of TGF-beta signaling","volume":"113","author":"Miyazono","year":"2000","journal-title":"J Cell Sci"},{"key":"key20180107181600_b36-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/39369","article-title":"Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling","volume":"389","author":"Nakao","year":"1997","journal-title":"Nature"},{"key":"key20180107181600_b37-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0092-8674(00)80303-7","article-title":"The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling","volume":"89","author":"Hayashi","year":"1997","journal-title":"Cell"},{"key":"key20180107181600_b38-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell"},{"key":"key20180107181600_b39-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2006.03.044","article-title":"PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling","volume":"125","author":"Lin","year":"2006","journal-title":"Cell"},{"key":"key20180107181600_b40-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/cr.2008.325","article-title":"Nucleocytoplasmic shuttling of Smad proteins","volume":"19","author":"Hill","year":"2009","journal-title":"Cell Res"},{"key":"key20180107181600_b41-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"19945","DOI":"10.1074\/jbc.M102382200","article-title":"Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts","volume":"276","author":"Piek","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107181600_b42-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/383168a0","article-title":"Receptor-associated Mad homologues synergize as effectors of the TGF-beta response","volume":"383","author":"Zhang","year":"1996","journal-title":"Nature"},{"key":"key20180107181600_b43-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"10669","DOI":"10.1073\/pnas.94.20.10669","article-title":"Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells","volume":"94","author":"Liu","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107181600_b44-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1165\/rcmb.2009-0282OC","article-title":"c-Jun N-terminal kinase 1 promotes transforming growth factor-\u03b21-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3","volume":"44","author":"Velden","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key20180107181600_b45-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"26793","DOI":"10.1074\/jbc.M212187200","article-title":"Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells","volume":"278","author":"Hirashima","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180107181600_b46-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2009.02.025","article-title":"Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats","volume":"51","author":"Hu","year":"2009","journal-title":"J Hepatol"},{"key":"key20180107181600_b47-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cytogfr.2005.09.010","article-title":"Smad3 phosphorylation by cyclin-dependent kinases","volume":"17","author":"Liu","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20180107181600_b48-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1074\/jbc.M809281200","article-title":"Transforming growth factor-{beta}-inducible phosphorylation of Smad3","volume":"284","author":"Wang","year":"2009","journal-title":"J Biol Chem"},{"key":"key20180107181600_b49-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1096\/fj.03-0037fje","article-title":"Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells","volume":"17","author":"Hayashida","year":"2003","journal-title":"FASEB J"},{"key":"key20180107181600_b50-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res"},{"key":"key20180107181600_b51-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.biocel.2009.12.023","article-title":"The TAK1-TRAF6 signalling pathway","volume":"42","author":"Landstrom","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107181600_b52-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ncb1780","article-title":"The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner","volume":"10","author":"Sorrentino","year":"2008","journal-title":"Nat Cell Biol"},{"key":"key20180107181600_b53-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.molcel.2008.09.002","article-title":"TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta","volume":"31","author":"Yamashita","year":"2008","journal-title":"Mol Cell"},{"key":"key20180107181600_b54-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","article-title":"A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches","volume":"143","author":"Seki","year":"2012","journal-title":"Gastroenterology"},{"key":"key20180107181600_b55-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1053\/j.gastro.2009.06.045","article-title":"c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice","volume":"137","author":"Kodama","year":"2009","journal-title":"Gastroenterology"},{"key":"key20180107181600_b56-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1172\/JCI37156","article-title":"Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation","volume":"118","author":"Hui","year":"2008","journal-title":"J Clin Invest"},{"key":"key20180107181600_b57-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.276.5309.60","article-title":"Liver regeneration","volume":"276","author":"Michalopoulos","year":"1997","journal-title":"Science"},{"key":"key20180107181600_b58-ijo-45-04-1363","doi-asserted-by":"crossref","DOI":"10.1002\/9781444341294","volume-title":"Sherlock\u2019s Disease of the Liver and Biliary System","author":"Dooley","year":"2011","edition":"12th edition"},{"key":"key20180107181600_b59-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/jhep.2002.30083","article-title":"Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury","volume":"35","author":"Tahashi","year":"2002","journal-title":"Hepatology"},{"key":"key20180107181600_b60-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fphys.2012.00053","article-title":"Differential regulation of TGF-beta\/Smad signaling in hepatic stellate cells between acute and chronic liver injuries","volume":"3","author":"Yoshida","year":"2012","journal-title":"Front Physiol"},{"key":"key20180107181600_b61-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"key20180107181600_b62-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ncpgasthep0055","article-title":"Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications","volume":"1","author":"Friedman","year":"2004","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"key20180107181600_b63-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20180107181600_b64-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI116769","article-title":"Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo","volume":"92","author":"Rockey","year":"1993","journal-title":"J Clin Invest"},{"key":"key20180107181600_b65-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(00)80413-4","article-title":"New aspects of hepatic fibrosis","volume":"32","author":"Brenner","year":"2000","journal-title":"J Hepatol"},{"key":"key20180107181600_b66-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"d1899","DOI":"10.2741\/A887","article-title":"Chemokines in liver inflammation and fibrosis","volume":"7","author":"Marra","year":"2002","journal-title":"Front Biosci"},{"key":"key20180107181600_b67-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(97)00024-0","article-title":"Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells","volume":"403","author":"Reimann","year":"1997","journal-title":"FEBS Lett"},{"key":"key20180107181600_b68-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI114363","article-title":"Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells","volume":"84","author":"Pinzani","year":"1989","journal-title":"J Clin Invest"},{"key":"key20180107181600_b69-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.510270222","article-title":"Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells","volume":"27","author":"Rockey","year":"1998","journal-title":"Hepatology"},{"key":"key20180107181600_b70-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.510300406","article-title":"Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor\u2019s actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat","volume":"30","author":"Marra","year":"1999","journal-title":"Hepatology"},{"key":"key20180107181600_b71-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0676.1991.tb00499.x","article-title":"Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis","volume":"11","author":"Nouchi","year":"1991","journal-title":"Liver"},{"key":"key20180107181600_b72-ijo-45-04-1363","first-page":"1233","article-title":"Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers","volume":"138","author":"Schmitt-Graff","year":"1991","journal-title":"Am J Pathol"},{"key":"key20180107181600_b73-ijo-45-04-1363","first-page":"785","article-title":"Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis","volume":"148","author":"Pinzani","year":"1996","journal-title":"Am J Pathol"},{"key":"key20180107181600_b74-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1053\/he.2000.6126","article-title":"Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts","volume":"31","author":"Dooley","year":"2000","journal-title":"Hepatology"},{"key":"key20180107181600_b75-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"29308","DOI":"10.1074\/jbc.M003282200","article-title":"Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation","volume":"275","author":"Stopa","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107181600_b76-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0016-5085(03)00666-8","article-title":"Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats","volume":"125","author":"Dooley","year":"2003","journal-title":"Gastroenterology"},{"key":"key20180107181600_b77-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.22934","article-title":"The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin- 13 as driving forces in fibrogenesis","volume":"50","author":"Weng","year":"2009","journal-title":"Hepatology"},{"key":"key20180107181600_b78-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"key20180107181600_b79-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3322\/canjclin.49.1.33","article-title":"Global cancer statistics","volume":"49","author":"Parkin","year":"1999","journal-title":"Cancer J Clin"},{"key":"key20180107181600_b80-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1007117","article-title":"Epidemiology of primary liver cancer","volume":"19","author":"Bosch","year":"1999","journal-title":"Semin Liver Dis"},{"key":"key20180107181600_b81-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3892\/ijo.2013.1829","article-title":"Human hepatocyte carcinogenesis (Review)","volume":"42","author":"Shiraha","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107181600_b82-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1101\/gr.133926.111","article-title":"The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients","volume":"22","author":"Jiang","year":"2012","journal-title":"Genome Res"},{"key":"key20180107181600_b83-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/286533a0","article-title":"Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma","volume":"286","author":"Brechot","year":"1980","journal-title":"Nature"},{"key":"key20180107181600_b84-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJM198110293051807","article-title":"Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens","volume":"305","author":"Shafritz","year":"1981","journal-title":"N Engl J Med"},{"key":"key20180107181600_b85-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2005.02.005","article-title":"The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma","volume":"42","author":"Bonilla Guerrero","year":"2005","journal-title":"J Hepatol"},{"key":"key20180107181600_b86-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2006.11.010","article-title":"Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis","volume":"252","author":"Feitelson","year":"2007","journal-title":"Cancer Lett"},{"key":"key20180107181600_b87-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.onc.1200850","article-title":"The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice","volume":"14","author":"Terradillos","year":"1997","journal-title":"Oncogene"},{"key":"key20180107181600_b88-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.humpath.2004.09.012","article-title":"c-myc overexpression in hepatocarcinogenesis","volume":"35","author":"Feitelson","year":"2004","journal-title":"Hum Pathol"},{"key":"key20180107181600_b89-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/jhep.2000.19343","article-title":"Hepatitis C virus core protein activates the MAPK\/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha","volume":"32","author":"Hayashi","year":"2000","journal-title":"Hepatology"},{"key":"key20180107181600_b90-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/viro.2001.1227","article-title":"Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line","volume":"292","author":"Erhardt","year":"2002","journal-title":"Virology"},{"key":"key20180107181600_b91-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1128\/JVI.76.18.9207-9217.2002","article-title":"Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase","volume":"76","author":"He","year":"2002","journal-title":"J Virol"},{"key":"key20180107181600_b92-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1042\/bj20031587","article-title":"Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1","volume":"378","author":"Qadri","year":"2004","journal-title":"Biochem J"},{"key":"key20180107181600_b93-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yexcr.2004.12.024","article-title":"Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK\/ERK signaling pathway via cellular receptors","volume":"305","author":"Zhao","year":"2005","journal-title":"Exp Cell Res"},{"key":"key20180107181600_b94-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2005.01.008","article-title":"Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth","volume":"333","author":"Hassan","year":"2005","journal-title":"Virology"},{"key":"key20180107181600_b95-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1074\/jbc.M512438200","article-title":"Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein","volume":"281","author":"Choi","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107181600_b96-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/hep.22849","article-title":"Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways","volume":"49","author":"Hassan","year":"2009","journal-title":"Hepatology"},{"key":"key20180107181600_b97-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"30711","DOI":"10.1074\/jbc.M209623200","article-title":"Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2","volume":"278","author":"Park","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180107181600_b98-ijo-45-04-1363","first-page":"25092518.e1","article-title":"Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner","volume":"138","author":"Lin","year":"2010","journal-title":"Gastroenterology"},{"key":"key20180107181600_b99-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","article-title":"Hepatitis C virus core protein induces hepatic steatosis in transgenic mice","volume":"78","author":"Moriya","year":"1997","journal-title":"J Gen Virol"},{"key":"key20180107181600_b100-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Moriya","year":"1998","journal-title":"Nat Med"},{"key":"key20180107181600_b101-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/gast.2002.31001","article-title":"Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus","volume":"122","author":"Lerat","year":"2002","journal-title":"Gastroenterology"},{"key":"key20180107181600_b102-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"e72252","DOI":"10.1371\/journal.pone.0072252","article-title":"Comparative analysis of TGF-beta\/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines","volume":"8","author":"Dzieran","year":"2013","journal-title":"PLoS One"},{"key":"key20180107181600_b103-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199910213411702","article-title":"Lamivudine as initial treatment for chronic hepatitis B in the United States","volume":"341","author":"Dienstag","year":"1999","journal-title":"N Engl J Med"},{"key":"key20180107181600_b104-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"key":"key20180107181600_b105-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","article-title":"A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B","volume":"354","author":"Chang","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107181600_b106-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","article-title":"Telbivudine versus lamivudine in patients with chronic hepatitis B","volume":"357","author":"Lai","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180107181600_b107-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2125.1998.00836.x","article-title":"Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions","volume":"46","author":"Khakoo","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"key20180107181600_b108-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-132-7-200004040-00002","article-title":"Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy","volume":"132","author":"Shiratori","year":"2000","journal-title":"Ann Intern Med"},{"key":"key20180107181600_b109-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.23744","article-title":"Outcome of sustained virological responders with histologically advanced chronic hepatitis C","volume":"52","author":"Morgan","year":"2010","journal-title":"Hepatology"},{"key":"key20180107181600_b110-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-131-3-199908030-00003","article-title":"Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy","volume":"131","author":"Yoshida","year":"1999","journal-title":"Ann Intern Med"},{"key":"key20180107181600_b111-ijo-45-04-1363","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0168-8278(99)80123-8","article-title":"Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection","volume":"30","author":"Suzuki","year":"1999","journal-title":"J Hepatol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2552\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T11:24:28Z","timestamp":1689420268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":111,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,7,22]]},"published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.3892\/ijo.2014.2552"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2552","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]}}}